Shanghai Haoyuan Chemexpress Co. Ltd. A (688131) - Total Assets
Based on the latest financial reports, Shanghai Haoyuan Chemexpress Co. Ltd. A (688131) holds total assets worth CN¥6.49 Billion CNY (≈ $949.62 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check 688131 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Shanghai Haoyuan Chemexpress Co. Ltd. A - Total Assets Trend (2013–2025)
This chart illustrates how Shanghai Haoyuan Chemexpress Co. Ltd. A's total assets have evolved over time, based on quarterly financial data. Check 688131 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Shanghai Haoyuan Chemexpress Co. Ltd. A - Asset Composition Analysis
Current Asset Composition (December 2025)
Shanghai Haoyuan Chemexpress Co. Ltd. A's total assets of CN¥6.49 Billion consist of 60.2% current assets and 39.8% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 24.3% |
| Accounts Receivable | CN¥646.06 Million | 10.3% |
| Inventory | CN¥1.41 Billion | 22.3% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥154.55 Million | 2.5% |
| Goodwill | CN¥377.52 Million | 6.0% |
Asset Composition Trend (2013–2025)
This chart illustrates how Shanghai Haoyuan Chemexpress Co. Ltd. A's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see 688131 market cap overview.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Shanghai Haoyuan Chemexpress Co. Ltd. A's current assets represent 60.2% of total assets in 2025, a decrease from 91.4% in 2013.
- Cash Position: Cash and equivalents constituted 24.3% of total assets in 2025, up from 9.4% in 2013.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 8.0% of total assets, an increase from 0.0% in 2013.
- Asset Diversification: The largest asset category is inventory at 22.3% of total assets.
Shanghai Haoyuan Chemexpress Co. Ltd. A Competitors by Total Assets
Key competitors of Shanghai Haoyuan Chemexpress Co. Ltd. A based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Tonghua Dongbao Pharmaceutical Co Ltd
SHG:600867
|
China | CN¥8.25 Billion |
|
Eris Lifesciences Limited
NSE:ERIS
|
India | Rs71.60 Billion |
|
Zhejiang Hisun Pharmaceutical Co Ltd
SHG:600267
|
China | CN¥13.81 Billion |
|
Lotus Pharmaceutical Co Ltd
TW:1795
|
Taiwan | NT$106.15 Billion |
|
Tasly Pharmaceutical Group Co Ltd
SHG:600535
|
China | CN¥15.69 Billion |
|
Changzhou Qianhong Biopharma Co Ltd
SHE:002550
|
China | CN¥3.23 Billion |
|
Renhe Pharmacy Co Ltd
SHE:000650
|
China | CN¥7.93 Billion |
|
Sun Pharma Advanced Research Company Limited
NSE:SPARC
|
India | Rs3.22 Billion |
Shanghai Haoyuan Chemexpress Co. Ltd. A - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.16 | 2.47 | 8.12 |
| Quick Ratio | 1.34 | 1.56 | 6.88 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥2.15 Billion | CN¥2.00 Billion | CN¥1.52 Billion |
Shanghai Haoyuan Chemexpress Co. Ltd. A - Advanced Valuation Insights
This section examines the relationship between Shanghai Haoyuan Chemexpress Co. Ltd. A's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 4.75 |
| Latest Market Cap to Assets Ratio | 0.43 |
| Asset Growth Rate (YoY) | 14.3% |
| Total Assets | CN¥6.29 Billion |
| Market Capitalization | $2.68 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Shanghai Haoyuan Chemexpress Co. Ltd. A's assets below their book value (0.43x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Shanghai Haoyuan Chemexpress Co. Ltd. A's assets grew by 14.3% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Shanghai Haoyuan Chemexpress Co. Ltd. A (2013–2025)
The table below shows the annual total assets of Shanghai Haoyuan Chemexpress Co. Ltd. A from 2013 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥6.29 Billion ≈ $921.05 Million |
+14.34% |
| 2024-12-31 | CN¥5.50 Billion ≈ $805.55 Million |
+31.31% |
| 2023-12-31 | CN¥4.19 Billion ≈ $613.45 Million |
+16.52% |
| 2022-12-31 | CN¥3.60 Billion ≈ $526.46 Million |
+50.88% |
| 2021-12-31 | CN¥2.38 Billion ≈ $348.93 Million |
+178.29% |
| 2020-12-31 | CN¥856.84 Million ≈ $125.38 Million |
+57.95% |
| 2019-12-31 | CN¥542.49 Million ≈ $79.38 Million |
+78.17% |
| 2018-12-31 | CN¥304.48 Million ≈ $44.55 Million |
+58.85% |
| 2017-12-31 | CN¥191.68 Million ≈ $28.05 Million |
+22.72% |
| 2016-12-31 | CN¥156.19 Million ≈ $22.86 Million |
+109.78% |
| 2015-12-31 | CN¥74.46 Million ≈ $10.90 Million |
+29.75% |
| 2014-12-31 | CN¥57.39 Million ≈ $8.40 Million |
+66.38% |
| 2013-12-31 | CN¥34.49 Million ≈ $5.05 Million |
-- |
About Shanghai Haoyuan Chemexpress Co. Ltd. A
Shanghai Haoyuan Chemexpress Co., Ltd. researches, develops, and manufactures pharmaceutical intermediates and small molecule drugs. The company offers APIs and API intermediates, vitamin D series compounds, CRO building blocks, and CRO life bioscience compounds. The company was founded in 2006 and is headquartered in Shanghai, China.